These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1361749)

  • 1. Studies of prognostic markers in HIV infection: implications for pathogenesis.
    Phillips AN
    AIDS; 1992 Nov; 6(11):1391-4. PubMed ID: 1361749
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
    An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of cells positive for HIV-1 p24 antigen assessed by flow cytometry.
    Holzer TJ; Heynen CA; Novak RM; Pitrak DL; Dawson GJ
    AIDS; 1993 Nov; 7 Suppl 2():S3-5. PubMed ID: 7909224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Italian Register for HIV Infection in Children.
    Italian Register for HIV Infection in Children
    Lancet; 1994 Jan; 343(8891):191-5. PubMed ID: 7904665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
    An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 status and P24 antigenemia. Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy?
    Butler KM; Husson RN; Lewis LL; Mueller BU; Venzon D; Pizzo PA
    Am J Dis Child; 1992 Aug; 146(8):932-6. PubMed ID: 1353299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.
    Farzadegan H; Chmiel JS; Odaka N; Ward L; Poggensee L; Saah A; Phair JP
    J Infect Dis; 1992 Dec; 166(6):1217-22. PubMed ID: 1358985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum beta 2-microglobulin in HIV infection.
    Krämer A; Goedert JJ; Wachter H; Fuchs D
    Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
    Tamalet C; Masquelier B; Ferchal F; Agut H; Puel J; Brun-Vézinet F; Fleury H; Rouzioux C
    AIDS; 1992 Nov; 6(11):1403-4. PubMed ID: 1361750
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings.
    Mofenson LM; Harris DR; Moye J; Bethel J; Korelitz J; Read JS; Nugent R; Meyer W;
    Lancet; 2003 Nov; 362(9396):1625-7. PubMed ID: 14630444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.
    Crocchiolo PR; Lizioli A; Cantaluppi P; Filippi C; D'Agostino F; Cambié G; Panzeri MP; Nardella ML
    J Clin Lab Immunol; 1990 Feb; 31(2):55-7. PubMed ID: 1983767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
    Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
    AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial.
    Drusano GL; Yuen GJ; Lambert JS; Seidlin M; Dolin R; Valentine FT
    Ann Intern Med; 1992 Apr; 116(7):562-6. PubMed ID: 1347442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
    Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD
    Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory methods for diagnosing and monitoring HIV infection.
    Grady C; Vogel S
    J Assoc Nurses AIDS Care; 1993; 4(2):11-21; quiz 22-3. PubMed ID: 8369497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of HIV-infection: markers or determinants.
    Phair JP; Farzadegan H; Chmiel J; Muñoz A; Detels R; Saah A; Kaslow R
    Trans Am Clin Climatol Assoc; 1993; 104():123-8; discussion 128-9. PubMed ID: 1364186
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune activation markers and AIDS prognosis.
    Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
    AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
    Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
    Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.